MedElevator
Войти в исследования Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
Integrated photoprotection and senescence modulation: A topical formulation counteracts cellular aging in human skin cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rzeszutek Iwona, Tomaszewska Anna, Rumian Dominika, Kulpa-Greszta Magdalena, Deręgowska Anna, Adamczyk-Grochala Jagoda, Romerowicz-Misielak Maria, Kostrzewa Tomasz, Barańska-Rybak Wioletta, Górska-Ponikowska Magdalena
Аннотация
BACKGROUND: Skin aging is driven by the accumulation of senescent cells that release a pro-inflammatory mediators, which collectively disrupt tissue homeostasis. Beside ultraviolet A (UVA) and ultraviolet B (UVB) radiation, high-energy visible blue-violet (HEV) light contributes to oxidative stress, mitochondrial dysfunction and premature keratinocyte senescence. A novel photoprotective topical formulation comprising hydroxyapatite, fermented oils, baicalin and crocin was developed to counteract these effects. This study evaluated its biological effect in human skin cell models under basal conditions, oxidative stress-induced premature senescence (SIPS) and HEV exposure.
METHODS: Human dermal fibroblasts (HDFs) and immortalized keratinocytes (HaCaT) were treated with the topical formulation (0.001-1 µg/mL). Metabolic activity, long-term cell survival, apoptosis, cell cycle distribution and cell migration were evaluated using MTT, trypan blue, flow cytometry and scratch assays. Photoprotective activity of TF against HEV blue-violet light at 445 and 465 nm was evaluated by MTT assay. Stress-induced premature senescence (SIPS) was induced with H₂O₂ and assessed by senescence-associated β-galactosidase (SA-β-gal) activity. Senostatic/senolytic potential was analyzed by imaging cytometry measuring p21, IL-6 and IL-8 levels. In vivo dermal tolerability was confirmed in patch tests involving 50 volunteers, including atopic and sensitive skin subjects.
RESULTS: The topical formulation increased keratinocyte viability and promoted long-term survival of both, fibroblasts and keratinocytes, without altering cell cycle distribution. In senescent cells, it reduced SA-β-gal activity and IL-6 and IL-8 levels suggesting attenuation of senescence phenotype. Pre-application of the formulation significantly protected keratinocytes against 445 nm (11 J·cm-2) HEV irradiation. Patch testing confirmed excellent tolerability with no signs of irritation or sensitization.
CONCLUSION: The multicomponent topical formulation exerted senostatic, anti-inflammatory and HEV-photoprotective activity, combined with confirmed in vivo tolerability in sensitive skin, supporting its potential use in skin anti-aging applications.
METHODS: Human dermal fibroblasts (HDFs) and immortalized keratinocytes (HaCaT) were treated with the topical formulation (0.001-1 µg/mL). Metabolic activity, long-term cell survival, apoptosis, cell cycle distribution and cell migration were evaluated using MTT, trypan blue, flow cytometry and scratch assays. Photoprotective activity of TF against HEV blue-violet light at 445 and 465 nm was evaluated by MTT assay. Stress-induced premature senescence (SIPS) was induced with H₂O₂ and assessed by senescence-associated β-galactosidase (SA-β-gal) activity. Senostatic/senolytic potential was analyzed by imaging cytometry measuring p21, IL-6 and IL-8 levels. In vivo dermal tolerability was confirmed in patch tests involving 50 volunteers, including atopic and sensitive skin subjects.
RESULTS: The topical formulation increased keratinocyte viability and promoted long-term survival of both, fibroblasts and keratinocytes, without altering cell cycle distribution. In senescent cells, it reduced SA-β-gal activity and IL-6 and IL-8 levels suggesting attenuation of senescence phenotype. Pre-application of the formulation significantly protected keratinocytes against 445 nm (11 J·cm-2) HEV irradiation. Patch testing confirmed excellent tolerability with no signs of irritation or sensitization.
CONCLUSION: The multicomponent topical formulation exerted senostatic, anti-inflammatory and HEV-photoprotective activity, combined with confirmed in vivo tolerability in sensitive skin, supporting its potential use in skin anti-aging applications.